125 related articles for article (PubMed ID: 2938656)
1. Identification of new metabolites of phosphoramide and nor-nitrogen mustards and cyclophosphamide in rat urine using ion cluster techniques.
Chan KK; Hong SC; Watson E; Deng SK
Biomed Environ Mass Spectrom; 1986 Mar; 13(3):145-54. PubMed ID: 2938656
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of hydrolysis in vitro of nornitrogen mustard, a metabolite of phosphoramide mustard and cyclophosphamide.
Hemminki K; Alhonen A; Linkola E; Hesso A
Arch Toxicol; 1987 Dec; 61(2):126-30. PubMed ID: 3439884
[TBL] [Abstract][Full Text] [Related]
3. Identification and quantitation of alcophosphamide, a metabolite of cyclophosphamide, in the rat using chemical ionization mass spectrometry.
Hong PS; Chan KK
Biomed Environ Mass Spectrom; 1987 Apr; 14(4):167-72. PubMed ID: 2954602
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of 4-hydroxycyclophosphamide and metabolites in the rat.
Hong PS; Srigritsanapol A; Chan KK
Drug Metab Dispos; 1991; 19(1):1-7. PubMed ID: 1673381
[TBL] [Abstract][Full Text] [Related]
5. Approaches to the pharmacokinetics of cyclophosphamide (NSC 26271): Quantitation of metabolites.
Jardine I; Brundrett R; Colvin M; Fenselau C
Cancer Treat Rep; 1976 Apr; 60(4):403-8. PubMed ID: 1277214
[TBL] [Abstract][Full Text] [Related]
6. Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.
Jardine I; Fenselau C; Appler M; Kan MN; Brundrett RB; Colvin M
Cancer Res; 1978 Feb; 38(2):408-15. PubMed ID: 620410
[TBL] [Abstract][Full Text] [Related]
7. Isolation and mass spectral identification of blood metabolites of cyclophosphamide: evidence for phosphoramide mustard as the biologically active metabolite.
Struck RF; Kirk MC; Witt MH; Laster WR
Biomed Mass Spectrom; 1975 Feb; 2(1):46-52. PubMed ID: 1131393
[TBL] [Abstract][Full Text] [Related]
8. The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometry.
Momerency G; Van Cauwenberghe K; Slee PH; Van Oosterom AT; De Bruijn EA
Biol Mass Spectrom; 1994 Mar; 23(3):149-58. PubMed ID: 8148406
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic detoxification of phosphoramide mustard by soluble fractions from rat organ tissues.
Hong PS; Chan KK
Drug Metab Dispos; 1991; 19(3):568-73. PubMed ID: 1680621
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of cyclophosphamide and metabolites with and without SR-2508.
Chan KK; Hong PS; Tutsch K; Trump DL
Cancer Res; 1994 Dec; 54(24):6421-9. PubMed ID: 7987837
[TBL] [Abstract][Full Text] [Related]
11. Gas chromatographic-mass spectrometric assay for N-2-chloroethylaziridine, a volatile cytotoxic metabolite of cyclophosphamide, in rat plasma.
Lu H; Chan KK
J Chromatogr B Biomed Appl; 1996 Apr; 678(2):219-25. PubMed ID: 8738025
[TBL] [Abstract][Full Text] [Related]
12. Toxicity, interstrand cross-links and DNA fragmentation induced by 'activated' cyclophosphamide in yeast: comparative studies on 4-hydroperoxy-cyclophosphamide, its monofunctional analogon, acrolein, phosphoramide mustard, and nor-nitrogen mustard.
Fleer R; Brendel M
Chem Biol Interact; 1982 Mar; 39(1):1-15. PubMed ID: 7037214
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of deuterium-labeled analogs of cyclophosphamide and its metabolites.
Griggs LJ; Jarman M
J Med Chem; 1975 Nov; 18(11):1102-6. PubMed ID: 1177255
[TBL] [Abstract][Full Text] [Related]
14. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
Hemminki K
Cancer Res; 1985 Sep; 45(9):4237-43. PubMed ID: 4028012
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy.
Juma FD; Rogers HJ; Trounce JR
Br J Clin Pharmacol; 1980 Oct; 10(4):327-35. PubMed ID: 7448105
[No Abstract] [Full Text] [Related]
16. Identification and pharmacokinetics of cyclophosphamide (NSC-26271) metabolites in vivo.
Voelcker G; Wagner T; Hohorst HJ
Cancer Treat Rep; 1976 Apr; 60(4):415-22. PubMed ID: 1277216
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of N-2-chloroethylaziridine, a volatile cytotoxic metabolite of cyclophosphamide, in the rat.
Lu H; Chan KK
Cancer Chemother Pharmacol; 2006 Oct; 58(4):532-9. PubMed ID: 16470409
[TBL] [Abstract][Full Text] [Related]
18. Detection of mutagenic activity in urine samples using a new concentration procedure.
Duverger-van Bogaert M; Stecca C; LĂ©onard A
Mutat Res; 1987 May; 178(1):21-4. PubMed ID: 3553913
[TBL] [Abstract][Full Text] [Related]
19. Protonation of phosphoramide mustard and other phosphoramides.
Gamcsik MP; Ludeman SM; Shulman-Roskes EM; McLennan IJ; Colvin ME; Colvin OM
J Med Chem; 1993 Nov; 36(23):3636-45. PubMed ID: 8246232
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the major sheep urinary metabolites of cyclophosphamide, a defleecing chemical.
Bakke JE; Feil VJ; Zaylskie RG
J Agric Food Chem; 1971; 19(4):788-90. PubMed ID: 5163862
[No Abstract] [Full Text] [Related]
[Next] [New Search]